journal article Oct 01, 2012

High‐Altitude Pulmonary Edema

Comprehensive Physiology Vol. 2 No. 4 pp. 2753-2773 · Wiley
View at Publisher Save 10.1002/j.2040-4603.2012.tb00459.x
Abstract
Abstract

High‐altitude pulmonary edema (HAPE), a not uncommon form of acute altitude illness, can occur within days of ascent above 2500 to 3000 m. Although life‐threatening, it is avoidable by slow ascent to permit acclimatization or with drug prophylaxis. The critical pathophysiology is an excessive rise in pulmonary vascular resistance or hypoxic pulmonary vasoconstriction (HPV) leading to increased microvascular pressures. The resultant hydrostatic stress causes dynamic changes in the permeability of the alveolar capillary barrier and mechanical injurious damage leading to leakage of large proteins and erythrocytes into the alveolar space in the absence of inflammation. Bronchoalveolar lavage and hemodynamic pressure measurements in humans confirm that elevated capillary pressure induces a high‐permeability noninflammatory lung edema. Reduced nitric oxide availability and increased endothelin in hypoxia are the major determinants of excessive HPV in HAPE‐susceptible individuals. Other hypoxia‐dependent differences in ventilatory control, sympathetic nervous system activation, endothelial function, and alveolar epithelial active fluid reabsorption likely contribute additionally to HAPE susceptibility. Recent studies strongly suggest nonuniform regional hypoxic arteriolar vasoconstriction as an explanation for how HPV occurring predominantly at the arteriolar level causes leakage. In areas of high blood flow due to lesser HPV, edema develops due to pressures that exceed the dynamic and structural capacity of the alveolar capillary barrier to maintain normal fluid balance. This article will review the pathophysiology of the vasculature, alveolar epithelium, innervation, immune response, and genetics of the lung at high altitude, as well as therapeutic and prophylactic strategies to reduce the morbidity and mortality of HAPE. Published 2012.
Compr Physiol
2:2753‐2773, 2012.
Topics

No keywords indexed for this article. Browse by subject →

References
234
[15]
Bärtsch P "Salmeterol for the prevention of high‐altitude pulmonary edema" N Engl J Med (2002)
[16]
Bärtsch P "Effects of slow ascent to 4559 M on fluid homeostasis" Aviat Space Environ Med (1991)
[46]
DeFouw DO "Ultrastructural freatures of alveolar epithelial transport" Am Rev Respir Dis (1983)
[49]
Dehnert C "Normal BMPR‐2 gene in individuals susceptible to high altitude pulmonary edema" High Alt Med Biol (2002)

Showing 50 of 234 references

Cited By
37
Metrics
37
Citations
234
References
Details
Published
Oct 01, 2012
Vol/Issue
2(4)
Pages
2753-2773
License
View
Cite This Article
Erik R. Swenson, Peter Bärtsch (2012). High‐Altitude Pulmonary Edema. Comprehensive Physiology, 2(4), 2753-2773. https://doi.org/10.1002/j.2040-4603.2012.tb00459.x
Related

You May Also Like

Lack of Exercise Is a Major Cause of Chronic Diseases

Frank W. Booth, Christian K. Roberts · 2012

519 citations

Triglyceride Metabolism in the Liver

Michele Alves‐Bezerra, David E. Cohen · 2018

311 citations

Neural Control of the Lower Urinary Tract

William C. de Groat, Derek Griffiths · 2015

230 citations

Motor Learning

John W. Krakauer, Alkis M. Hadjiosif · 2019

180 citations

Satellite Cells and Skeletal Muscle Regeneration

Nicolas A. Dumont, C. Florian Bentzinger · 2015

172 citations